This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Hangzhou Innogate Pharma Co., Ltd.. Active years: 2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021
Title: Wenting Chen: Innovator in Heterocyclic Compounds
Introduction
Wenting Chen is a notable inventor based in Zhejiang, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of heterocyclic compounds.
Latest Patents
Wenting Chen holds a patent for a heterocyclic compound that acts as a Syk inhibitor and/or Syk-HDAC dual inhibitor. This patent includes pharmaceutically acceptable salts, prodrugs, deuterated derivatives, hydrates, and solvates. Specifically, the compound of formula (I) demonstrates dual inhibitory activity for Syk and/or Syk-HDAC.
Career Highlights
Wenting Chen is associated with Hangzhou Innogate Pharma Co., Ltd., where he continues to advance his research and development efforts. His work focuses on innovative solutions in the pharmaceutical industry.
Collaborations
Wenting Chen collaborates with talented individuals such as Hancheng Zhang and Shifeng Liu, contributing to a dynamic research environment.
Conclusion
Wenting Chen's innovative work in heterocyclic compounds showcases his commitment to advancing pharmaceutical science. His contributions are paving the way for new therapeutic options.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile